跳至主要内容
临床试验/EUCTR2007-000513-12-CZ
EUCTR2007-000513-12-CZ进行中(未招募)1 期

Terlipressin in the treatment of catecholamine-resistant septic shock - Terlipressin in septic shock

Úrazová nemocnice brno0 个研究点目标入组 40 人开始时间: 2007年2月8日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age >18 years
  • Male or non-pregnant female
  • Refractory septic shock (norepinehprine 0.3 microg/kg/min) with hemodynamic instability (MAP<60 mm Hg)
  • Proven or suspected bacterial infection
  • Informed consent in accordance with Act 129/2003, §34, sect. 8 or 3d and GCP E6, sect. 4.8.15)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Known hypersensitivity to terlipressine
  • Acute coronary artery disease
  • Vasospastic diathesis
  • Acute mesenteric ischemia

研究者

发起方
Úrazová nemocnice brno

相似试验